Inventiva (IVEVF) Long-Term Debt Repayments (2019 - 2025)
Inventiva (IVEVF) posted Long-Term Debt Repayments of -$2.0 million for Q2 2025, down 59.95% on a QoQ basis from -$1.3 million in Q2 2024, and down 59.95% year-over-year from -$5.1 million in Q2 2024.
Analysis
Inventiva (IVEVF) Long-Term Debt Repayments (2019 - 2025) Analysis & Trends
Inventiva has reported Long-Term Debt Repayments for 5 years, with the latest figure at -$2.0 million in Q2 2025.
- On a quarterly basis, Long-Term Debt Repayments fell 59.95% year-over-year to -$2.0 million in Q2 2025; TTM through Jun 2025 was -$3.3 million, a 154.98% decrease from a year earlier, with the FY2025 full-year figure at -$3.8 million, down 36.56% from the prior year.
- Long-Term Debt Repayments was -$2.0 million for Q2 2025 at Inventiva, down from -$1.3 million in the prior quarter.
- The five-year high for Long-Term Debt Repayments was -$14871.6 in Q4 2021, with the low at -$2.0 million in Q2 2025.
- Average Long-Term Debt Repayments over 3 years is -$831347.3, with a median of -$641588.9 recorded in 2021.
- The sharpest annual moves came in 2021 and 2025: Long-Term Debt Repayments jumped 74.01% in 2021, then tumbled 59.95% in 2025.
- Over 3 years, Long-Term Debt Repayments stood at -$14871.6 in 2021, then slumped by 8422.92% to -$1.3 million in 2024, then tumbled by 59.95% to -$2.0 million in 2025.
- The last three Long-Term Debt Repayments figures came in at -$2.0 million (Q2 2025), -$1.3 million (Q2 2024), and -$14871.6 (Q4 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | - |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 2.00 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | 5.00 Mn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | - |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -2.03 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Dec 31, 2021 | -14,871.62 |
| Mar 31, 2021 | -15,681.07 |
| Dec 31, 2020 | -57,229.91 |
| Jun 30, 2020 | -15,420.44 |
| Mar 31, 2020 | -37,533.93 |
| Dec 31, 2019 | -80,802.80 |